Thiazole-based Chalcone Derivatives as Potential Anti-inflammatory Agents: Biological Evaluation and Molecular Modelling

Author(s): Christophe Tratrat*, Michelyne Haroun, Evangelia Tsolaki, Anthi Petrou, Antonis Gavalas, Athina Geronikaki*

Journal Name: Current Topics in Medicinal Chemistry

Volume 21 , Issue 4 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Inflammation is a multifactorial process reflecting the response of the organism to various stimuli and is associated with a number of disorders such as arthritis, asthma and psoriasis, which require long-lasting or repeated treatment.

Objective: The aim of this paper is to evaluate the anti-inflammatory activity of previous synthesized thiazole-based chalcone derivatives.

Methods: Chalcones were synthesized via Cliazen-Schmidt condensation1-(4-methyl-2- alkylamino)thiazol-5-yl) ethanone with a corresponding aromatic aldehyde. For the evaluation of possible anti-inflammatory activity, carrageenan mouse paw edema was used.

Results: Eight out of thirteen tested chalcones showed anti-inflammatory activity in a range of 51- 55%. Prediction of toxicity revealed that these compounds are not toxic.

Conclusion: In general, it can be concluded that these compounds can be used for further modifications in order to develop more active and safe agents.

Keywords: Thiazole, Chalcone, NSAIDs, Toxicity, Docking, LOX.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 21
ISSUE: 4
Year: 2021
Published on: 14 December, 2020
Page: [257 - 268]
Pages: 12
DOI: 10.2174/1568026621999201214232458
Price: $65

Article Metrics

PDF: 20